Michael H. Goldstein Insider Profile
4 Followers
Michael H. Goldstein, President, Ophthalmology & CMO at Ocular Therapeutix, holds 313.33K shares in Ocular Therapeutix (Ticker: OCUL), holds ― shares in Applied Genetic Technologies (Ticker: AGTC).
Michael H. Goldstein's Trading History
| OCULOcular Therapeutix | Feb 07, 2022 | President, Ophthalmology & CMO | Uninformative Buy | ― | $1.88M | |
| AGTCApplied Genetic Technologies | ― | ― | ― | ― |
You May Also Like
Michael H. Goldstein insider profile FAQ
What stocks does Michael H. Goldstein hold?
Michael H. Goldstein holds: OCUL, AGTC stocks.
What is Michael H. Goldstein's role in Ocular Therapeutix?
Michael H. Goldstein's role in Ocular Therapeutix is President, Ophthalmology & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
